Q: Hi Peter, can I get an update thought on Colony please. It's had a nice run up. And what's your view on REITs in general moving forward? Thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Good morning. Broadcom results seem fine yet Morningstar report has then as a sell?
Comments please. Stephen S
Comments please. Stephen S
Q: I am intrigued by how VEEV has succeeded over the last 5 years. In 2015, one commentator on BNN stated that salesforce (CRM) would likely crush VEEV, because all VEEV did was customize existing software (so reduced start-up costs) and sell it in the life sciences vertical, while undercutting its competitors on price. It then quickly gained market share. Why did VEEV succeed and how did it fend off CRM and others? How big is VEEV's "moat"?
Q: I saw this company in a screener today, had never heard of it before and was surprised to see no questions on it. What are your thoughts on it?
Thanks!
Thanks!
Q: Contemplating selling VGT and buying ARKK. The only thing stopping me is ARKK's 10% investment in TESLA. Would you stay away from ARKK given its strong bet on this one stock with a history of volatility? Additionally, how do you see TESLA's price (and therefore ARKK's) being impacted by TESLA's addition later this month to the S&P500? Thank you.
Q: online shopping is expected to be at all time records. and the use of cash continues to decline. what is your current opinion of visa and MasterCard ? and will the new method of buying (ie 3 or 4 equal instalments). have any material effect on the 2 companies? thanks Richard
-
iShares Russell Mid-Cap ETF (IWR $95.70)
-
iShares Russell 1000 Growth ETF (IWF $471.02)
-
iShares Russell 2000 Value ETF (IWN $180.15)
Q: Hi group going fwd at this point which is the best ETF in the Russell group of ETFs value or growth, small cap or mid cap or? Thanks
Q: Your current thoughts please. I see they focus on email. Is this any concern? I wonder because I am a slow footed dinosaur and don’t know what or where the next technology t-Rex is coming from. Thanks.
-
Defiance Next Gen Connectivity ETF (FIVG)
-
KraneShares CICC China 5G and Semiconductor Index ETF (KFVG)
Q: Good morning
FIVG or KFVG
Your comments please and thank you.
Sincerely
Mike
FIVG or KFVG
Your comments please and thank you.
Sincerely
Mike
-
Axon Enterprise Inc. (AAXN)
-
Zendesk Inc. (ZEN)
-
BlackLine Inc. (BL $57.76)
-
Fastly Inc. Class A (FSLY $12.34)
-
Datadog Inc. (DDOG $158.99)
Q: Hi 5i,
Would you recommend any of the 5 stocks listed? If so, what order would you recommend?
Thanks,
Jon
Would you recommend any of the 5 stocks listed? If so, what order would you recommend?
Thanks,
Jon
Q: Hi 5i team,
I will use XBC as an example here. It is now approaching $1B market cap. You guys always seem to reference this as a magic threshold that can bring in bigger investors that either don’t like the small cap space or are not permitted there by their mandate. I am curious if this is a key threshold for just Canadian companies or is the threshold typically higher for U.S. companies, where the cap sizes are proportionately higher.
Thanks again for the insight.
Dave
I will use XBC as an example here. It is now approaching $1B market cap. You guys always seem to reference this as a magic threshold that can bring in bigger investors that either don’t like the small cap space or are not permitted there by their mandate. I am curious if this is a key threshold for just Canadian companies or is the threshold typically higher for U.S. companies, where the cap sizes are proportionately higher.
Thanks again for the insight.
Dave
-
Akamai Technologies Inc. (AKAM $90.71)
-
Cisco Systems Inc. (CSCO $76.32)
-
Fastly Inc. Class A (FSLY $12.34)
Q: There is a rumor that CISCO might buy FSLY. If they do what price range will it go for. How much Debt or CASH does FSLY hold. News is only on some site. Is there anything on Bloomberg?
Do you think CISCO is a good fit or any other company that might be interested to buy?
Thanks for the great service
Hector
Do you think CISCO is a good fit or any other company that might be interested to buy?
Thanks for the great service
Hector
Q: Hi 5i team,
I need to increase my holdings in industrial stocks and am thinking of either TT or LMT, hoping they have a strong enough balance sheets and growth potential to come out on top after the pandemic shutdown. Which one would you buy now and why or other preference? Would you answer be different if the vaccines are not as effective and the economy lock down dragged on through 2021? Thanks.
I need to increase my holdings in industrial stocks and am thinking of either TT or LMT, hoping they have a strong enough balance sheets and growth potential to come out on top after the pandemic shutdown. Which one would you buy now and why or other preference? Would you answer be different if the vaccines are not as effective and the economy lock down dragged on through 2021? Thanks.
Q: Kindly provide your opinion of this ETF as a clean energy play. Do you prefer another ETF in the same space over QCLN?
Best, Don
Best, Don
Q: Could I please get your thoughts on these two US names and current valuation and if good entry points
Q: Do you like this Stock and would you be a buyer for long term hold. Do you think investors should be concerned about US govt trying to break up company - what do you think is likelyhood and if it does happen impact on the stock?
Q: Do you have any thoughts on CleanSpark (CLSK)... I notice that the stock has been moving . Thanks
Tom
Tom
Q: Atara Biotherapeutics (NASDAQ:ATRA) has announced presentation of preclinical data of ATA3219 at American Society of Hematology.
Their allogeneic CAR T-cell therapy targeting CD19, Bayer has also just entered into an exclusive worldwide license agreement, for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors with Atara.
What is your opinion on this company and it's medium and long term investment potential.
Their allogeneic CAR T-cell therapy targeting CD19, Bayer has also just entered into an exclusive worldwide license agreement, for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors with Atara.
What is your opinion on this company and it's medium and long term investment potential.
Q: Hi, what are your thoughts about the company? They skyrocketed over the last week or so but it seems to me all speculations. I'd be curious to hear your thoughts and whether I should sell now or hold. Thank you!
Q: C3.AI (symbol AI) Would appreciate your opinion of this new ipo ? today ?
JOHN
JOHN